Azopt

Azopt is a brand name of brinzolamide ophthalmic, approved by the FDA in the following formulation(s):

AZOPT (brinzolamide - suspension/drops; ophthalmic)

• 
  Manufacturer: ALCON PHARMS LTD
  
  Approval date: April 1, 1998
  
  Strength(s): 1% ^[RLD]

Has a generic version of Azopt been approved?

No. There is currently no therapeutically equivalent version of Azopt available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Azopt. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Sulfonamides useful as carbonic anhydrase inhibitors
  Patent 5,378,703
  Issued: January 3, 1995
  Inventor(s): Dean; Thomas R. & Chen; Hwang-Hsing & May; Jesse A.
  Assignee(s): Alcon Laboratories, Inc.
  Sulfonamides and pharmaceutical compositions containing the compounds useful in controlling intraocular pressure are disclosed. Methods for controlling intraocular pressure through administration of the compositions are also disclosed.
  
  Patent expiration dates:
  
  
  • April 1, 2012
    
    ✓ 
    Patent use: CONTROLLING INTRAOCULAR PRESSURE
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  
  
  • October 1, 2012
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Topical ophthalmic pharmaceutical vehicles
  Patent 5,461,081
  Issued: October 24, 1995
  Inventor(s): Ali; Yusuf & Reed; Kenneth W.
  Assignee(s): Alcon Laboratories, Inc.
  Universal ophthalmic pharmaceutical vehicles which increase in viscosity upon instillation in the eye are disclosed. Ophthalmic compositions of the universal vehicle and a pharmaceutically active drug are also disclosed. In one embodiment, the vehicle gels upon instillation in the eye. In another embodiment, suspension vehicles having superior physical stability are provided.
  
  Patent expiration dates:
  
  
  • October 24, 2012
    
    ✓ 
    Patent use: MEHTOD FOR DELIVERY
    ✓ 
    Drug product
  
  
  
  • April 24, 2013
    
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Azopt Drops Consumer Information (Wolters Kluwer)
• Azopt Consumer Information (Cerner Multum)
• Azopt Advanced Consumer Information (Micromedex)
• Azopt 1% Advanced Consumer Information (Micromedex)
• Azopt AHFS DI Monographs (ASHP)
• Brinzolamide Drops Consumer Information (Wolters Kluwer)
• Brinzolamide ophthalmic Consumer Information (Cerner Multum)
• Brinzolamide Ophthalmic Advanced Consumer Information (Micromedex)
• Brinzolamide AHFS DI Monographs (ASHP)